Threonine.

Threonine is converted to glycine through the threonine dehydrogenase and threonine aldolase routes, so threonine intake feeds the glycine pool directly. Both amino acids are then drawn on heavily for connective tissue and gut mucin protein synthesis.

Pyridoxal 5-phosphate, the active form of vitamin B6, is the coenzyme for threonine dehydratase and threonine aldolase. Without adequate B6 status the enzymes that route threonine into glycine and into energy metabolism run slowly.

O-linked sugar chains attach to the hydroxyl side chains of serine and threonine residues, and mucin proteins of the gut lining are unusually rich in both. Supplying the two together matches how the mucus layer is actually built.

In cereal and plant protein, lysine is the first limiting essential amino acid and threonine is usually next, so protein formulation has paired them for decades. Adding threonine without lysine leaves the same ceiling on how much of the protein the body can use.

Threonine breakdown produces propionyl-CoA, which is carboxylated and then rearranged to succinyl-CoA by a B12-dependent mutase. That last step stops without B12.

Propionyl-CoA carboxylase, the enzyme handling threonine-derived propionyl-CoA, depends on biotin. Biotin status gates that exit.

The ketoacid dehydrogenase complex that processes threonine-derived 2-oxobutyrate carries an FAD component. Riboflavin keeps that flavin charged.

The ketoacid dehydrogenase step downstream of threonine uses NAD as its electron acceptor. Niacin maintains that pool.

Threonine carbon travels as acyl-CoA intermediates, so coenzyme A availability limits the route. Pantothenic acid is the precursor of that coenzyme.

Threonine is the most abundant amino acid in intestinal mucin and glutamine is the enterocyte's preferred fuel. Gut formulas carry both so mucus turnover has substrate and energy.

Threonine and lysine are the amino acids most often limiting in cereal protein, so blends balance them together. Raising one alone leaves the same ceiling in place.

Mucin is threonine-rich while the intestinal lining runs on glutamine as fuel. Supplying both covers substrate and energy for normal mucus turnover.

The dehydrogenase route oxidises threonine to 2-amino-3-ketobutyrate using NAD+ as the electron acceptor, and that intermediate is cleaved to glycine and acetyl-CoA. Without an oxidised NAD pool the route stalls and flux shifts toward the dehydratase pathway instead. This is settled enzymology and needs no combination trial to state.

Glycine produced from threonine is either used for protein synthesis or cleaved by the glycine cleavage system, which loads a one-carbon unit onto tetrahydrofolate. Folate availability therefore sets how much of that glycine can be disposed of through the one-carbon route rather than accumulating. The link is established metabolism; it is not a claim that threonine changes folate status.

The dehydratase route removes water and ammonia from threonine to give alpha-ketobutyrate, which is decarboxylated to propionyl-CoA. In bacteria that same alpha-ketobutyrate is the committed precursor of isoleucine, which is why fermentation strains engineered to overproduce threonine have to manage the isoleucine branch. In humans the two amino acids converge on propionyl-CoA rather than on each other.

Threonine and the branched-chain amino acids are absorbed through overlapping neutral amino acid transporters, so a large free-form bolus of one lowers the uptake rate of the others taken at the same moment. The effect is on rate and timing rather than on total absorption from a mixed meal. It is the main reason single free amino acids behave differently from the same amino acids inside a protein.

Valine and threonine compete for the same class of sodium-dependent neutral amino acid transporters in the small intestine. When free amino acids are given together in large amounts, uptake of each is slower than when either is given alone. Inside an intact protein the competition largely disappears because peptide transport handles most of the load.

Free tryptophan and free threonine draw on shared neutral amino acid transport, so timing matters when both are taken as isolated powders. The practical size of this competition at supplement intakes has not been characterised in humans. Read it as a transport mechanism rather than a measured interaction.

Threonine is an indispensable amino acid, so all of it comes from the diet, and a complete protein such as whey supplies it in proportion with the other eight. Adding free threonine on top of an adequate protein intake changes the balance of the free amino acid pool rather than filling a gap. Where total protein is low, the protein source is what determines threonine supply.

Collagen peptides are not a complete protein: they carry almost no tryptophan and comparatively little threonine, so a diet leaning on collagen for protein needs its indispensable amino acids from elsewhere. Threonine sits alongside that gap because it is also the residue that carries most O-linked glycosylation. Pairing them is about completing the profile, not about a combination effect.

The combination was tested together in laying birds, with the authors reporting changes in the amino acid composition of eggs relative to the control diet. The rationale offered is that a bacterial supplement alters gut conditions and mucin turnover, and threonine is the amino acid mucin draws on most heavily. This is a non-human feeding study and does not carry across to people as an effect.

O-linked glycosylation attaches N-acetylgalactosamine to the hydroxyl of a serine or threonine residue, and mucins carry hundreds of such sites per molecule. Amino sugar availability and threonine availability therefore both feed the same glycoprotein assembly. The connection is biochemical; no combination has been tested at supplement intakes.

Phenylalanine is a large neutral amino acid that shares carrier capacity with threonine at the intestinal brush border. Taken as free powders at the same time, each slows the other's uptake. The magnitude at ordinary supplement doses is not established.

Tyrosine and threonine are both neutral amino acids taken up by overlapping transporters, so a large free-form dose of one changes the timing of the other. Spacing free amino acid doses apart removes the question. This is transport physiology, not an observed clinical interaction.

Histidine and threonine are absorbed through overlapping carriers, so simultaneous large free-form doses compete. Both are also indispensable, so a shortfall in either limits protein synthesis regardless of how much of the other is present. The competition is transport-level and short-lived; the indispensability point is the more consequential one.

Casein clots in the stomach and releases amino acids over several hours, giving a slower and flatter rise in plasma threonine than a free amino acid dose. That difference in delivery shape matters more than total threonine content for how the amino acid is used. Both routes supply the same molecule.